<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 3: Pharmacology & HRT Synergy: Collaborative Care Models | AccrediPro</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 40px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

.welcome-box h3 {
 color: #722F37;
 font-size: 18px;
 font-weight: 700;
 margin-bottom: 12px;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #7e22ce;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 list-style: none;
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
}

/* DATA TABLE */
.data-table { width: 100%; border-collapse: collapse; margin: 25px 0; font-size: 15px; border-radius: 12px; overflow: hidden; box-shadow: 0 4px 12px rgba(0,0,0,0.05); }
.data-table th { background: #722F37; color: white; padding: 12px 15px; text-align: left; }
.data-table td { padding: 12px 15px; border-bottom: 1px solid #e5e7eb; }
.data-table tr:nth-child(even) { background: #f9fafb; }

/* COACH TIP BOX */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip::before {
 content: 'üí°';
 position: absolute;
 top: -12px;
 left: 24px;
 background: white;
 padding: 4px 8px;
 border-radius: 8px;
 font-size: 20px;
 box-shadow: 0 2px 8px rgba(0,0,0,0.08);
}

.tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 16px;
 margin: 0;
}

.case-study-content {
 padding: 28px;
}

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}
.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}
.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}
.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}
.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* KEY TAKEAWAYS */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}
.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}
.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
}
.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
 list-style: disc;
}

/* REFERENCES */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box .box-label {
 color: #64748b;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 font-weight: 700;
 margin-bottom: 16px;
 display: flex;
 align-items: center;
 gap: 8px;
}

.references-box ol {
 padding-left: 20px;
}

.references-box li {
 font-size: 14px;
 color: #475569;
 margin-bottom: 8px;
}

/* MODULE CONNECTION */
.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.module-connection .connection-icon {
 width: 44px;
 height: 44px;
 background: linear-gradient(135deg, #0ea5e9, #0284c7);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 22px;
 flex-shrink: 0;
 color: white;
}
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 24: Master Practitioner Skills</span>
 <h1 class="lesson-title">Pharmacology & HRT Synergy: Collaborative Care Models</h1>
 <div class="lesson-meta">
 <span class="meta-badge">Lesson 3 of 8</span>
 <span class="meta-badge">‚è±Ô∏è 15 min read</span>
 <span class="meta-badge">Master Practitioner Level</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">A</div>
 <div class="asi-text">
 <div class="label">AccrediPro Standards Institute Verified</div>
 <div class="title">Clinical Collaboration & Pharmacological Integration Standards</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <p class="box-label">In This Lesson</p>
 <ul class="toc-list">
 <li><a href="#delivery-systems"><span class="section-num">01</span>HRT Delivery Systems</a></li>
 <li><a href="#side-effects"><span class="section-num">02</span>Side Effects vs. Adjustment</a></li>
 <li><a href="#medical-advocacy"><span class="section-num">03</span>The Art of the Clinical Brief</a></li>
 <li><a href="#nutrient-drug"><span class="section-num">04</span>Nutrient-Drug Interactions</a></li>
 <li><a href="#compounded"><span class="section-num">05</span>FDA vs. Compounded Bioidenticals</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-icon">üîó</div>
 <div class="connection-text">
 <p>While Lesson 2 focused on <strong>functional diagnostics</strong>, we now shift to the <strong>practical synergy</strong> between clinical pharmacology and the PHASE Framework‚Ñ¢. Understanding HRT delivery is essential for maximizing the "H" (Harmonize) pillar of our methodology.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>Mastering the Clinical Bridge</h3>
 <p>As a Master Practitioner, you are often the primary advocate for a client navigating the complexities of Menopause Hormone Therapy (MHT). This lesson equips you with the technical expertise to discuss delivery systems, manage expectations during the adjustment phase, and collaborate effectively with prescribing physicians to ensure the best possible outcomes for women in midlife.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Analyze the metabolic pathways of different HRT delivery systems to optimize bio-individual client selection.</li>
 <li>Differentiate between transient adjustment symptoms and persistent clinical side effects to improve client retention.</li>
 <li>Construct professional clinical briefs that facilitate effective collaboration with medical providers.</li>
 <li>Identify critical nutrient-drug interactions involving common midlife medications like Metformin and SSRIs.</li>
 <li>Evaluate the safety, efficacy, and clinical indications for FDA-approved vs. compounded bioidentical hormones.</li>
 </ul>
 </div>

 <h2 id="delivery-systems">I. Mastering HRT Delivery Systems</h2>
 <p>The success of hormone therapy often hinges not on the <em>dose</em>, but on the <em>delivery</em>. As a Master Practitioner, you must understand how different routes of administration affect the liver, clotting factors, and hormone stability.</p>
 
 <table class="data-table">
 <thead>
 <tr>
 <th>Delivery System</th>
 <th>Primary Advantage</th>
 <th>Clinical Note</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>Transdermal (Patches/Gels)</strong></td>
 <td>Bypasses the liver; lower risk of blood clots.</td>
 <td>Gold standard for women with high BMI or smoking history.</td>
 </tr>
 <tr>
 <td><strong>Oral Micronized Progesterone</strong></td>
 <td>Provides sedative effect; improves sleep architecture.</td>
 <td>Must be taken at night; metabolized into allopregnanolone.</td>
 </tr>
 <tr>
 <td><strong>Vaginal Estrogen (Local)</strong></td>
 <td>Minimal systemic absorption; targets GSM specifically.</td>
 <td>Can be used even by many women who cannot take systemic HRT.</td>
 </tr>
 <tr>
 <td><strong>Oral Estrogen (Traditional)</strong></td>
 <td>Increases SHBG; can lower free testosterone.</td>
 <td>Higher risk of VTE (clots) compared to transdermal routes.</td>
 </tr>
 </tbody>
 </table>

 <div class="coach-tip">
 <span class="tip-label">Master Practitioner Insight</span>
 <p>When a client reports skin irritation from a patch, don't immediately assume HRT is a failure. Suggest they discuss <strong>transdermal gels or sprays</strong> with their doctor. These offer the same liver-bypass benefits without the adhesive-related dermatitis.</p>
 </div>

 <h2 id="side-effects">II. Side Effects vs. Adjustment Symptoms</h2>
 <p>Client retention often fails in the first 90 days because women mistake the body's <strong>recalibration</strong> for a negative reaction. We categorize these into two distinct buckets:</p>
 
 <p><strong>1. Adjustment Symptoms (The 3-Month Window):</strong> These are transient. As estrogen receptors "wake up," clients may experience temporary breast tenderness, mild spotting, or slight bloating. In the PHASE Framework‚Ñ¢, we use the <strong>Stabilize (S)</strong> pillar to manage these through anti-inflammatory nutrition and hydration.</p>
 
 <p><strong>2. Clinical Side Effects:</strong> These are persistent and often indicate a dose-response mismatch. Examples include ongoing heavy uterine bleeding, persistent migraines, or significant mood destabilization. These require immediate medical consultation and a potential change in delivery method.</p>

 <!-- Case Study -->
 <div class="case-study">
 <div class="case-study-header">
 <div class="title">Case Study: The "Adjustment" Hurdle</div>
 </div>
 <div class="case-study-content">
 <p><strong>Client:</strong> Elena, 51, former litigation attorney (now wellness consultant).</p>
 <p><strong>Presentation:</strong> Elena started a 0.05mg estradiol patch and 100mg oral progesterone. At week 3, she called her practitioner ready to quit due to "intense breast soreness and feeling puffy."</p>
 <p><strong>Intervention:</strong> The practitioner explained the <strong>receptor upregulation process</strong>. She added 200mg of Magnesium Bisglycinate (to support Phase II detoxification) and encouraged Elena to wait until the 8-week mark.</p>
 <p><strong>Outcome:</strong> By week 7, the symptoms vanished. Elena now reports 100% resolution of her brain fog and hot flashes. Elena‚Äôs practitioner charges $250 for this "HRT Concierge" support, providing a high-value service that keeps clients on their medical protocols.</p>
 </div>
 </div>

 <h2 id="medical-advocacy">III. The Art of the Clinical Brief</h2>
 <p>One of the most valuable skills you can offer is <strong>Medical Advocacy</strong>. Most GPs have only 10-15 minutes per patient. When your client arrives with a <em>Clinical Brief</em> prepared by you, the quality of care skyrockets.</p>
 
 <p>A professional Clinical Brief should include:</p>
 <ul>
 <li><strong>Symptom Tracking Data:</strong> Quantitative data from the PHASE symptom tracker.</li>
 <li><strong>Functional Lab Highlights:</strong> (e.g., "Client's Ferritin is at 22 ng/mL, potentially contributing to fatigue despite HRT").</li>
 <li><strong>Client Goals:</strong> (e.g., "Client prioritizes bone density protection and sleep restoration").</li>
 <li><strong>The "Ask":</strong> A clear, respectful request for the physician to consider a specific delivery system (e.g., "Client is interested in discussing transdermal options due to a family history of gallbladder issues").</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Communication Tip</span>
 <p>Never "prescribe" or "diagnose." Instead, use phrases like: <em>"Based on the client's reported symptom patterns, we would appreciate your clinical evaluation of..."</em> This maintains professional boundaries while guiding the doctor toward the best solution.</p>
 </div>

 <h2 id="nutrient-drug">IV. Nutrient-Drug Interactions</h2>
 <p>HRT does not exist in a vacuum. Many midlife women are also prescribed Metformin (for insulin resistance), Statins (for cholesterol), or SSRIs (for mood). The PHASE Framework‚Ñ¢ requires us to understand how these interact.</p>
 
 <ul>
 <li><strong>Metformin & B12:</strong> Metformin can deplete Vitamin B12. If your client is on Metformin for metabolic health, you must ensure their B12 levels are optimized to prevent HRT-resistant fatigue.</li>
 <li><strong>SSRIs & Libido:</strong> If a client is on an SSRI for perimenopausal anxiety, it may mask the libido-boosting effects of HRT. This is a crucial "pattern recognition" moment for the Master Practitioner.</li>
 <li><strong>Statins & CoQ10:</strong> Statins deplete CoQ10, which is vital for the mitochondrial energy needed to process hormones effectively.</li>
 </ul>

 <h2 id="compounded">V. FDA-Approved vs. Compounded Bioidenticals</h2>
 <p>This is a frequent area of confusion for clients. As a specialist, you must provide an evidence-based perspective.</p>
 
 <p><strong>FDA-Approved Bioidenticals:</strong> These are regulated, standardized, and most importantly, <em>tested for safety and purity</em>. Examples include Prometrium (progesterone) and Estradot/Vivelle-Dot (estradiol). They are the first-line recommendation for most practitioners.</p>
 
 <p><strong>Compounded Hormones:</strong> These are custom-mixed by a pharmacist. While they allow for "boutique" dosing (like adding a tiny amount of testosterone to a cream), they lack the rigorous oversight of FDA products. They are best reserved for clients with specific allergies to excipients in standard medications.</p>

 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. Why is transdermal estrogen preferred over oral estrogen for a woman with a high BMI?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans1')">Reveal Answer</button>
 <div id="ans1" class="answer-text">Transdermal estrogen bypasses the first-pass metabolism in the liver. Oral estrogen stimulates the production of clotting factors in the liver, increasing the risk of venous thromboembolism (VTE), which is already higher in women with a high BMI.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. What is the recommended "waiting period" for transient adjustment symptoms?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans2')">Reveal Answer</button>
 <div id="ans2" class="answer-text">The "3-Month Window" (8-12 weeks) is generally recommended, as many symptoms like breast tenderness or mild bloating resolve once hormone receptors stabilize and down-regulate.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. Which nutrient is most commonly depleted by the long-term use of Metformin?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans3')">Reveal Answer</button>
 <div id="ans3" class="answer-text">Vitamin B12. Depletion can lead to fatigue, cognitive issues, and neuropathy, which can be mistaken for menopause symptoms.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. What is the primary clinical concern regarding compounded hormone pellets?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans4')">Reveal Answer</button>
 <div id="ans4" class="answer-text">The primary concern is the lack of dosage standardization and the inability to "turn off" or remove the dose once it is implanted if the patient experiences adverse effects (e.g., supraphysiological levels).</div>
 </div>
 </div>

 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li><strong>Delivery Matters:</strong> Transdermal delivery is safer for the liver and reduces clot risk, making it the preferred route for most midlife women.</li>
 <li><strong>The 90-Day Rule:</strong> Educate clients on the difference between adjustment symptoms (temporary) and side effects (persistent) to prevent premature cessation of therapy.</li>
 <li><strong>Collaborative Advocacy:</strong> Using Clinical Briefs establishes you as a professional peer to medical providers and ensures the client receives personalized care.</li>
 <li><strong>Nutrient Synergy:</strong> Always screen for medications like Metformin or SSRIs that may deplete nutrients or mask the benefits of HRT.</li>
 <li><strong>Bioidentical vs. Compounded:</strong> Prioritize FDA-approved bioidenticals for safety and consistency, using compounding only when medically necessary.</li>
 </ul>
 </div>

 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>The North American Menopause Society. (2022). "The 2022 Hormone Therapy Position Statement of The North American Menopause Society." <em>Menopause</em>.</li>
 <li>L‚ÄôHermite, M. (2017). "Bioidentical hormones: the medical dogma vs. the reality of compounding." <em>Gynecological Endocrinology</em>.</li>
 <li>Stuenkel, C. A., et al. (2015). "Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline." <em>Journal of Clinical Endocrinology & Metabolism</em>.</li>
 <li>Maki, P. M., et al. (2019). "Guidelines for the evaluation and treatment of perimenopausal depression." <em>Journal of Women's Health</em>.</li>
 <li>Aroda, V. R., et al. (2016). "Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study." <em>Journal of Clinical Endocrinology & Metabolism</em>.</li>
 <li>Newson, L. R. (2020). "Menopause and Hormone Replacement Therapy: A Guide for GPs." <em>British Journal of General Practice</em>.</li>
 </ol>
 </div>
</div>

<script>
function toggleAnswer(id) {
 const el = document.getElementById(id);
 if (el.style.display === 'block') {
 el.style.display = 'none';
 } else {
 el.style.display = 'block';
 }
}
</script>

</body>
</html>